Clinical Trial Update: The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium [Phase 3]

View source ↗

Summary

Phase 3 trial update of Chinese-made Praziquantel for Schistosoma haematobium infection. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis Haematobium

Drugs mentioned

• Praziquantel (Praziquantel)

Snippet

Sponsor: Jiangsu Institute of Parasitic Diseases | Conditions: Schistosomiasis Haematobia | Phase 3 | Status: UNKNOWN